Semaglutide has a hypoglycemic effect and can regulate appetite and digestive function. It is a long-acting glucagon-like peptide-1 (GLP-1) analog and a GLP-1 receptor agonist with potential therapeutic efficacy for type 2 diabetes mellitus (T2DM). Furthermore, semaglutide has shown cardiovascular protective activity in clinical trials, reducing the risk of major adverse cardiovascular events (MACE).
Semaglutide Bioactivity
Apr 18, 2026
Leave a message
Looking for High-qualityWeight Loss Peptides?
With reliable stock, fast bulk delivery, custom packaging and OEM/ODM services, we aim to be your trusted partner for peptide raw materials.